UBS Knock-Out VRTX/ DE000UH4V0R2 /
2024-11-11 1:26:27 PM | Chg.+0.020 | Bid1:26:27 PM | Ask1:26:27 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
2.720EUR | +0.74% | 2.720 Bid Size: 20,000 |
2.750 Ask Size: 20,000 |
Vertex Pharmaceutica... | 231.5308 USD | 2078-12-31 | Call |
Master data
Issuer: | UBS AG, LONDON BRANCH |
---|---|
WKN: | UH4V0R |
Currency: | EUR |
Underlying: | Vertex Pharmaceuticals Inc |
Type: | Knock-out |
Option type: | Call |
Strike price: | 231.5308 USD |
Maturity: | Endless |
Issue date: | 2021-11-30 |
Last trading day: | 2078-12-31 |
Ratio: | 100:1 |
Exercise type: | Bermuda |
Quanto: | No |
Gearing: | 1.78 |
Knock-out: | 231.5308 |
Knock-out violated on: | - |
Distance to knock-out: | 265.1077 |
Distance to knock-out %: | 55.09% |
Distance to strike price: | 265.1077 |
Distance to strike price %: | 55.09% |
Calculated values
Fair value: | - |
---|---|
Implied volatility: | - |
Historic volatility: | - |
Parity: | - |
Time value: | - |
Break-even: | - |
Moneyness: | - |
Premium: | 0.01 |
Premium p.a.: | 0.00 |
Spread abs.: | 0.01 |
Spread %: | 0.37% |
Delta: | - |
Theta: | - |
Omega: | - |
Rho: | - |
Quote data
Open: | 2.690 |
---|---|
High: | 2.730 |
Low: | - |
Market phase: | - |
All quotes in EUR
Performance
1 Week | +20.89% | ||
---|---|---|---|
1 Month | +16.24% | ||
3 Months | +20.89% | ||
YTD | +51.96% | ||
1 Year | +77.78% | ||
3 Years | - | ||
5 Years | - | ||
10 Years | - |
1W High / 1W Low: | 2.700 | 2.250 |
---|---|---|
1M High / 1M Low: | 2.700 | 2.240 |
6M High / 6M Low: | 2.700 | 1.940 |
High (YTD): | 2024-11-08 | 2.700 |
Low (YTD): | 2024-04-30 | 1.640 |
52W High: | 2024-11-08 | 2.700 |
52W Low: | 2023-11-16 | 1.220 |
Avg. price 1W: | 2.492 | |
Avg. volume 1W: | 0.000 | |
Avg. price 1M: | 2.363 | |
Avg. volume 1M: | 0.000 | |
Avg. price 6M: | 2.309 | |
Avg. volume 6M: | 0.000 | |
Avg. price 1Y: | 2.043 | |
Avg. volume 1Y: | 0.000 | |
Volatility 1M: | 55.29% | |
Volatility 6M: | 41.37% | |
Volatility 1Y: | 51.01% | |
Volatility 3Y: | - |